Influence of promoter/enhancer region haplotypes on MGMT transcriptional regulation: a potential biomarker for human sensitivity to alkylating agents.
about
The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomideThe tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.The MGMT promoter single-nucleotide polymorphism rs1625649 had prognostic impact on patients with MGMT methylated glioblastoma.Differential effect of ABCB1 haplotypes on promoter activity.
P2860
Influence of promoter/enhancer region haplotypes on MGMT transcriptional regulation: a potential biomarker for human sensitivity to alkylating agents.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Influence of promoter/enhancer ...... sitivity to alkylating agents.
@en
Influence of promoter/enhancer ...... sitivity to alkylating agents.
@nl
type
label
Influence of promoter/enhancer ...... sitivity to alkylating agents.
@en
Influence of promoter/enhancer ...... sitivity to alkylating agents.
@nl
prefLabel
Influence of promoter/enhancer ...... sitivity to alkylating agents.
@en
Influence of promoter/enhancer ...... sitivity to alkylating agents.
@nl
P2093
P2860
P356
P1433
P1476
Influence of promoter/enhancer ...... sitivity to alkylating agents.
@en
P2093
Catherine M Rondelli
Courtney E Cross
Ilona Nekhayeva
Jeffrey K Wickliffe
Meixiang Xu
Sherif Z Abdel-Rahman
P2860
P304
P356
10.1093/CARCIN/BGT355
P407
P577
2013-10-25T00:00:00Z